Back to Authors

Sorenson, Karl R

Mayo Clinic

Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.

Citations 1

Biomarkers for prognosis in pancreatic neuroendocrine tumors
Zhu, Mojun , Sorenson, K, Sorenson, Karl R, Liu, Rebecca H. , Gould Rothberg, Bonnie E , Hálfdánarson, Þorvarður R.

Endocrine-Related Cancer | September 28, 2021 | Volume: 28 | Issue: 12 | Pages: 773-782

10.1530/erc-21-0075 Get It

Pancreatic neuroendocrine tumors (PNETs) encompass a diverse group of malignancies marked by histological heterogeneity and highly variable clinical outcomes. We performed a systematic review on potential prognostic biomarkers in PNETs by searching the PubMed database. A total of 472 manuscripts were reviewed in detail, of which 52 multivariate studies met the inclusion criteria proposed by the Reporting Recommendations for Tumor Marker Prognostic Studies. These altogether analyzed 53 unique targets, and 36 of them were statistically associated with survival.